Thomas Klopstock, MD
LMU Klinikum
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Elliott Vichinsky, MD
Children's Hospital & Research Center at Oakland Hematology/ Oncology, Pediatric Rehabilitation
Shared therapeutic areas:
Worked with same sponsors:
Penelope Hogarth, M.D.
Oregon Health and Science University
Shared therapeutic areas:
Thomas Klopstock, Prof. Dr.
LMU Klinikum, Friedrich-Baur-Institute
Shared therapeutic areas:
Fernando Tricta, MD
ApoPharma Inc.
Shared therapeutic areas:
Worked with same sponsors:
Thomas Klopstock, MD
Friedrich-Baur-Institute, Department of Neurology, University of Munich Ziemssenstr
Shared therapeutic areas:
Worked with same sponsors:
Susan J Hayflick, MD
Oregon Health and Science University
Shared therapeutic areas:
Patrick Chinnery, MD
Newcastle University Institute of Human Genetics
Shared therapeutic areas:
Worked with same sponsors:
Elliott Vichinsky, MD
UCSF Benioff Children's Hospital Oakland
Shared therapeutic areas:
Worked with same sponsors:
Nardo Nardocci, MD
Foundation Neurological Institute C. Besta
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants
Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
All 2 trials loaded